Back to search

Article

Cystatin-C versus Creatinine-Based eGFR in Bardet-Biedl Syndrome: Implications for Chronic Kidney Disease Detection

2026-07-27

Abstract excerpt

<title>Abstract</title> <p> Background Bardet–Biedl syndrome (BBS) is a rare multisystem ciliopathy with significant kidney involvement. Reliance on serum creatinine for estimating glomerular filtration rate (GFR) may underestimate impairment for children with reduced muscle mass or obesity. Cystatin-C is an alternative marker less affected by muscle mass, but its role in BBS surveillance remains under-explored...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dcc25352-74a1-59a9-a3c5-ed0ee6cb243f
DOI
10.21203/rs.3.rs-10403020/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cystatin-C versus Creatinine-Based eGFR in Bardet-Biedl Syndrome: Implications for Chronic Kidney Disease DetectionDOI 10.21203/rs.3.rs-10403020/v1
Select a neighboring publication to make it the new centre.